Fred Alger Management’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Fred Alger Management’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-875	Closed	-$245K	–	530
2016 Q4	$245K	Buy	+875	New	+$239K	﹤0.01%	346
2016 Q2	–	Sell	-4,108	Closed	-$1.43M	–	529
2016 Q1	$1.43M	Buy	+4,108	New	+$1.43M	0.01%	347
2014 Q4	–	Sell	-3,550	Closed	-$1.71M	–	581
2014 Q3	$1.71M	Buy	+3,550	New	+$1.89M	0.01%	412

Other funds holding BIS

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fred Alger Management's BIS Position: Q1 2017 in Review

Fred Alger Management sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q1 2017, closing a stake of 875 shares — an estimated $245K sold.

Fred Alger Management first reported a position in BIS in Q3 2014 and held it in 3 quarters. The position peaked at $1.71M in Q3 2014. 11 funds tracked by Wall St. Rank hold BIS as of Q1 2017.

Fred Alger Management reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q1 2017 after selling out during the quarter.
Fred Alger Management sold 875 ProShares UltraShort NASDAQ Biotechnology shares in Q1 2017, an estimated $245K.
Fred Alger Management first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q3 2014 and held it in 3 quarters.
Fred Alger Management's ProShares UltraShort NASDAQ Biotechnology position peaked at $1.71M in Q3 2014.
11 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q1 2017.

Based on Fred Alger Management's 13F filing for Q1 2017, filed 15 May 2017.